ストックスクリーナーアプリを入手
25.38
4.27%
1.04
アフターアワーズ：
25.29
-0.09
-0.35%
前日終値:
$24.34
開ける：
$24.42
24時間の取引高:
63,758
Relative Volume:
0.73
時価総額：
$539.17M
収益：
$54,000
当期純損益:
$-210.26M
株価収益率:
-32.13
EPS:
-0.79
ネットキャッシュフロー:
$-159.01M
1週間 パフォーマンス:
+12.10%
1か月 パフォーマンス:
+6.77%
6か月 パフォーマンス:
+140.11%
1年 パフォーマンス:
+136.40%
1日の値動き範囲:
$23.30
$26.11
1週間の範囲:
$21.07
$26.11
52週間の値動き範囲:
$7.65
$45.00
Lyell Immunopharma Inc Stock (LYEL) Company Profile
名前
Lyell Immunopharma Inc
セクター
電話
650 695-0677
住所
201 HASKINS WAY, SOUTH SAN FRANCISCO
Compare LYEL vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
25.38 | 517.08M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-10-30 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-06-27 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-11-14 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | ダウングレード | Goldman | Buy → Neutral |
| 2022-10-17 | 開始されました | H.C. Wainwright | Buy |
| 2021-07-12 | 開始されました | BofA Securities | Buy |
| 2021-07-12 | 開始されました | Goldman | Buy |
| 2021-07-12 | 開始されました | JP Morgan | Overweight |
| 2021-07-12 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Lyell Immunopharma Inc (LYEL) 最新ニュース
Lyell Immunopharma (NASDAQ:LYEL) COO Stephen Hill Sells 1,236 Shares - MarketBeat
Insider Selling: Lyell Immunopharma (NASDAQ:LYEL) CEO Sells 7,455 Shares of Stock - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Trading Up 7.3%Should You Buy? - MarketBeat
Lyell Immunopharma Announces Initiation Of Patient Dosing In First-Of-Its-Kind Phase 3 Car T-Cell Clinical Trial - TradingView
Lyell Immunopharma, Inc. (Lyell) announced that dosing has begun for patients with aggressive large B-cell lymphoma in a groundbreaking Phase 3 clinical trial. - Bitget
Inside the first head-to-head CAR T cancer trial testing Lyell’s ronde-cel - Stock Titan
Insider Selling: Lyell Immunopharma (NASDAQ:LYEL) CEO Sells 438 Shares of Stock - MarketBeat
Pullback Watch: Is Lyell Immunopharma Inc stock trending bullishJuly 2025 Setups & Daily Profit Focused Screening - baoquankhu1.vn
How do insiders feel about American Express CompanyIPO Watch & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Growth in Short Interest - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap UpShould You Buy? - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Trading 13.4% HigherWhat's Next? - MarketBeat
Earnings Beat: How volatile is Lyell Immunopharma Inc stock2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Update - Defense World
Entry Recap: Will Lyell Immunopharma Inc benefit from rate cutsExit Point & AI Forecast for Swing Trade Picks - baoquankhu1.vn
EPS Watch: What is the long term forecast for Lyell Immunopharma Inc stockPrice Action & Advanced Technical Signal Analysis - baoquankhu1.vn
How rising interest rates impact Lyell Immunopharma Inc. stock2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
Will Lyell Immunopharma Inc. stock benefit from automation2025 Price Targets & Fast Entry Momentum Trade Alerts - ulpravda.ru
Lyell Immunopharma (NASDAQ:LYEL) Shares Down 4.6%Here's Why - MarketBeat
Should I hold or sell Lyell Immunopharma Inc. stock in 2025Market Profile Overview & Low Cost Wealth Investment - bollywoodhelpline.com
Lyell Immunopharma (NASDAQ:LYEL) Shares Up 4.2%Still a Buy? - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Trading Down 6.7% – Should You Sell? - Defense World
Lyell Immunopharma (NASDAQ:LYEL) Shares Down 6.7%Here's Why - MarketBeat
The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar - sharewise.com
Critical Review: Lipocine (NASDAQ:LPCN) & Lyell Immunopharma (NASDAQ:LYEL) - Defense World
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow - Yahoo Finance
Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data (NASDAQ:LYEL) - Seeking Alpha
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
Lyell Immunopharma (NASDAQ:LYEL) Shares Up 5.5%Here's Why - MarketBeat
Lyell ImmunoPharma pops on recent ASH data, immunotherapy expansion - MSN
Lyell Immunopharma (NASDAQ:LYEL) Reaches New 1-Year HighTime to Buy? - MarketBeat
Lyell Immunopharma pops on recent ASH data, immunotherapy expansion - Seeking Alpha
Why Lyell Immunopharma Inc. stock could be next big winnerPortfolio Growth Summary & High Win Rate Trade Tips - Улправда
Will Lyell Immunopharma Inc. stock rally after Fed decisionsGold Moves & High Accuracy Swing Trade Signals - Улправда
Would You Still Hold Lyell Immunopharma Stock If It Fell 30%? - Trefis
Dip Buying: Is Lyell Immunopharma Inc. stock a smart buy before Fed meeting2025 Market Trends & Free Expert Verified Stock Movement Alerts - Улправда
What technical charts say about Lyell Immunopharma Inc. stock2025 Trading Recap & Risk Controlled Stock Pick Alerts - DonanımHaber
What analysts say about Lyell Immunopharma Inc stockGap Up/Gap Down Analysis & Free Rapid Wealth Building - earlytimes.in
CEO Change: Why Lyell Immunopharma Inc. stock could be next big winnerBond Market & Consistent Profit Trading Strategies - Улправда
Can Lyell Immunopharma Inc. stock reach $100 price target2025 Earnings Impact & Daily Profit Focused Screening - DonanımHaber
Is Lyell Immunopharma Inc. stock a safe buy before earningsPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - Улправда
Why Lyell Immunopharma Inc. stock could outperform in 20252025 Major Catalysts & Intraday High Probability Setup Alerts - DonanımHaber
Is Lyell Immunopharma Inc. stock a smart buy before Fed meetingJuly 2025 Chart Watch & Technical Pattern Recognition Alerts - Улправда
Lyell Immunopharma (LYEL) details 1.9M-share ICT resale and license terms - Stock Titan
Institutional investors are Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) biggest bettors and were rewarded after last week's US$72m market cap gain - Yahoo Finance
Lyell Immunopharma climbs after reporting strong CAR T-cell therapy results - MSN
China Universal Asset Management Co. Ltd. Has $26,000 Position in Lyell Immunopharma, Inc. $LYEL - Defense World
HSG Holding Ltd Cuts Position in Lyell Immunopharma, Inc. $LYEL - MarketBeat
1,820,634 Shares in Lyell Immunopharma, Inc. $LYEL Bought by ARCH Venture Management LLC - MarketBeat
Lyell Immunopharma Inc (LYEL) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):